EDIGENE Trademark

Trademark Overview


On Friday, April 15, 2022, a trademark application was filed for EDIGENE with the United States Patent and Trademark Office. The USPTO has given the EDIGENE trademark a serial number of 79343236. The federal status of this trademark filing is REGISTERED as of Tuesday, November 21, 2023. This trademark is owned by EDIGENE INC.. The EDIGENE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biological preparations for medical purposes for the treatment of gene mutation related diseases, hematological diseases and psychiatric and immune system related diseases and disorders; styptic preparations; medicines for human purposes, namely, medicines for the treatment of diabetes, obesity, cancer, viral, metabolic, endocrine, musculoskeletal, oncological diseases, cardiovascular and cerebrovascular diseases, respiratory diseases and asthma, gastrointestinal diseases, genitourinary diseases, neurological diseases, allergies, headaches, insomnia, bacteria-based diseases, ocular disorders or diseases; pharmaceutical preparations, namely, antivirals, pharmaceutical preparations for suppressing tumors, pharmaceutical preparations for the treatment of cancers; stem cells for medical purposes; surgical implants comprised of living tissues; blood products, namely, blood plasma, blood for medical purposes; biological preparations for the treatment of cancer; pharmaceutical preparations fo...

Biotechnology research; scientific research for medical purposes in the area of cancerous diseases; genetic testing for scientific research purposes; structural and functional analysis of genomes; DNA screening for scientific research purposes; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical research services; analysis of the mode of action of chemical combinations on animals; technological research in the field of novel drug development; scientific laboratory services; chemical research; biological research; scientific research in the nature of conducting clinical trials for others; medical research
edigene

General Information


Serial Number79343236
Word MarkEDIGENE
Filing DateFriday, April 15, 2022
Status700 - REGISTERED
Status DateTuesday, November 21, 2023
Registration Number7220512
Registration DateTuesday, November 21, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 5, 2023

Trademark Statements


Goods and ServicesBiological preparations for medical purposes for the treatment of gene mutation related diseases, hematological diseases and psychiatric and immune system related diseases and disorders; styptic preparations; medicines for human purposes, namely, medicines for the treatment of diabetes, obesity, cancer, viral, metabolic, endocrine, musculoskeletal, oncological diseases, cardiovascular and cerebrovascular diseases, respiratory diseases and asthma, gastrointestinal diseases, genitourinary diseases, neurological diseases, allergies, headaches, insomnia, bacteria-based diseases, ocular disorders or diseases; pharmaceutical preparations, namely, antivirals, pharmaceutical preparations for suppressing tumors, pharmaceutical preparations for the treatment of cancers; stem cells for medical purposes; surgical implants comprised of living tissues; blood products, namely, blood plasma, blood for medical purposes; biological preparations for the treatment of cancer; pharmaceutical preparations for activating cellular function; cytostatics for medical purposes; living cells for medical purposes; ophthalmological preparations; pharmaceutical preparations for ophthalmological use; cord blood for medical purposes
Goods and ServicesBiotechnology research; scientific research for medical purposes in the area of cancerous diseases; genetic testing for scientific research purposes; structural and functional analysis of genomes; DNA screening for scientific research purposes; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical research services; analysis of the mode of action of chemical combinations on animals; technological research in the field of novel drug development; scientific laboratory services; chemical research; biological research; scientific research in the nature of conducting clinical trials for others; medical research

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 24, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 24, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEDIGENE INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCN

Party NameEDIGENE INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCN

Party NameEDIGENE INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Monday, March 18, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 22, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, February 22, 2024FINAL DISPOSITION PROCESSED
Wednesday, February 21, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 21, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 21, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, September 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 5, 2023PUBLISHED FOR OPPOSITION
Monday, September 4, 2023NOTIFICATION PROCESSED BY IB
Wednesday, August 16, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 16, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 16, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 31, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 18, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 18, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 19, 2023REFUSAL PROCESSED BY IB
Wednesday, March 29, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, March 29, 2023REFUSAL PROCESSED BY MPU
Saturday, February 4, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, February 3, 2023NON-FINAL ACTION WRITTEN
Thursday, February 2, 2023ASSIGNED TO EXAMINER
Tuesday, June 28, 2022APPLICATION FILING RECEIPT MAILED
Friday, June 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 23, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB